Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Other | — | SEC | |
| Other | — | SEC | |
| Other | — | SEC | |
| Award | — | SEC | |
| Buy | $3.3M | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $3.3M | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $10.1M | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $36.3K | SEC | |
| Buy | $250K | SEC | |
| Buy | $66.9K | SEC | |
| Buy | $102.8K | SEC | |
| Buy | $326.3K | SEC | |
| Buy | $920K | SEC | |
| Buy | $267K | SEC | |
| Award | — | SEC | |
| Buy | $190.3K | SEC | |
| Buy | $492.8K | SEC | |
| Buy | $277.3K | SEC | |
| Buy | $437K | SEC | |
| Buy | $469.8K | SEC | |
| Buy | $469.8K | SEC | |
| Buy | $153.2K | SEC |